A detailed history of Jpmorgan Chase & CO transactions in Avita Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 32,344 shares of RCEL stock, worth $380,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,344
Previous 23,359 38.46%
Holding current value
$380,688
Previous $185,000 87.03%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$7.72 - $10.87 $69,364 - $97,666
8,985 Added 38.46%
32,344 $346,000
Q2 2024

Aug 12, 2024

BUY
$7.92 - $15.55 $103,554 - $203,316
13,075 Added 127.14%
23,359 $185,000
Q1 2024

May 10, 2024

SELL
$12.56 - $18.31 $79,680 - $116,158
-6,344 Reduced 38.15%
10,284 $164,000
Q4 2023

Feb 12, 2024

SELL
$9.29 - $14.57 $4,022 - $6,308
-433 Reduced 2.54%
16,628 $228,000
Q3 2023

Nov 14, 2023

SELL
$13.84 - $20.79 $33,645 - $50,540
-2,431 Reduced 12.47%
17,061 $249,000
Q2 2023

Aug 11, 2023

BUY
$10.7 - $17.48 $137,452 - $224,548
12,846 Added 193.29%
19,492 $331,000
Q1 2023

May 11, 2023

BUY
$6.45 - $14.48 $42,866 - $96,234
6,646 New
6,646 $92,000
Q2 2022

Aug 11, 2022

SELL
$4.6 - $8.82 $80,504 - $154,358
-17,501 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$6.96 - $12.15 $351,681 - $613,927
-50,529 Reduced 74.27%
17,501 $149,000
Q4 2021

Feb 10, 2022

BUY
$11.72 - $19.66 $209,811 - $351,953
17,902 Added 35.71%
68,030 $815,000
Q3 2021

Nov 12, 2021

BUY
$16.73 - $20.9 $838,641 - $1.05 Million
50,128 New
50,128 $889,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $295M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.